NinePointTwo Capital’s Novo Nordisk NVO Stock Holding History

NinePointTwo Capital’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$549K	Hold	5,310	–	–	0.22%	35
2023 Q3	$482K	Hold	5,310	–	–	0.2%	31
2023 Q2	$429K	Hold	5,310	–	–	0.17%	34
2023 Q1	$422K	Hold	5,310	–	–	0.16%	35
2022 Q4	$359K	Hold	5,310	–	–	0.15%	34
2022 Q3	$264K	Hold	5,310	–	–	0.11%	129
2022 Q2	$295K	Hold	5,310	–	–	0.1%	126
2022 Q1	$294K	Hold	5,310	–	–	0.08%	122
2021 Q4	$297K	Hold	5,310	–	–	0.1%	67
2021 Q3	$254K	Hold	5,310	–	–	0.1%	41
2021 Q2	$222K	Buy	+5,310	New	+$206K	0.08%	54

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

NinePointTwo Capital's NVO Position: Q4 2023 in Review

NinePointTwo Capital held its Novo Nordisk (NVO) position steady in Q4 2023 at 5,310 shares worth $549K. The position accounts for 0.22% of the portfolio, ranked #35.

NinePointTwo Capital first reported a position in NVO in Q2 2021 and has held it in 11 quarters since. 1,511 funds tracked by Wall St. Rank hold NVO as of Q4 2023.

NinePointTwo Capital held 5,310 shares of Novo Nordisk worth $549K as of Q4 2023.
NinePointTwo Capital left its Novo Nordisk share count unchanged in Q4 2023.
Novo Nordisk made up 0.22% of NinePointTwo Capital's portfolio in Q4 2023, its #35 holding.
NinePointTwo Capital first reported a position in Novo Nordisk in Q2 2021 and has held it in 11 quarters since.
1,511 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2023.

Based on NinePointTwo Capital's 13F filing for Q4 2023, filed 14 Feb 2024.